Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech Dip: Sector Weakness, or Buying Opportunity?
Biotech Dip: Sector Weakness, or Buying Opportunity?
Biotech Dip: Sector Weakness, or Buying Opportunity?
Submitted by
admin
on March 12, 2009 - 10:33am
Source:
Seeking Alpha
News Tags:
Amgen
Genentech
biotech
Gilead Sciences
Genzyme
Teva Pharmaceuticals
Mylan
Watson Pharmaceuticals
Headline:
Biotech Dip: Sector Weakness, or Buying Opportunity?
Do Not Allow Advertisers to Use My Personal information
